A Systematic Study of Assessment of Attention-Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder
About this trial
This is an interventional diagnostic trial for Attention Deficit Hyperactivity Disorder focused on measuring Assessment, Biomarkers, Patient satisfaction, Validity, Reliability
Eligibility Criteria
Inclusion Criteria:
- Age 8-17 years
- Referral for ADHD assessment
Exclusion Criteria:
- Suspected intellectual disability
- Substance abuse
- Psychosis
- Severe depression
- Parent not fluent in Swedish
- Child not living with legal guardian
- Child having protected identity
Sites / Locations
- Child and adolescent psychiatry unitRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
Brief assessment protocol
Comprehensive assessment protocol
The brief protocol will contain a minimum according to guidelines for assessing ADHD: review of medical records, a validated diagnostic interview (MINI-KID), a structured medical history, a pedagogical statement including suspicion of intellectual disability, and rating scales for symptoms such as ADHD, oppositional defiant disorder, autism, anxiety, and depression directed to children (≥ 13 years), parents, and teachers.
The comprehensive protocol will extend the brief protocol by adding an approximately three-hour long battery of neuropsychological tests (WISC-V and CPT 3) and biomarkers (heart-rate variability, pupil dilation and the pupillary light reflex) assessed during the CPT 3.